Ignite Creation Date:
2025-12-25 @ 12:56 AM
Ignite Modification Date:
2026-02-28 @ 3:30 AM
Study NCT ID:
NCT02023593
Status:
COMPLETED
Last Update Posted:
2023-02-16
First Post:
2013-12-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
FOLFIRI as Second Line Chemotherapy for Metastatic Esophageal Carcinoma
Sponsor:
Yuhong Li
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-03
Start Date Type:
ACTUAL
Primary Completion Date:
2019-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-12
Completion Date Type:
ACTUAL
First Submit Date:
2013-12-16
First Submit QC Date:
None
Study First Post Date:
2013-12-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-02-14
Last Update Post Date:
2023-02-16
Last Update Post Date Type:
ACTUAL